The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

Jun. 29, 2018
Applicants:

Yusheng Xiong, Plainsboro, NJ (US);

Hong-ping Guan, Scotch Plains, NJ (US);

Wenjun Huang, Doylestown, PA (US);

Quixgen, Inc., North Brunswick, NJ (US);

Inventors:

Yusheng Xiong, Plainsboro, NJ (US);

Hong-Ping Guan, Scotch Plains, NJ (US);

Wenjun Huang, Doylestown, PA (US);

Assignee:

Quixgen, Inc., North Brunswick, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61P 17/10 (2006.01); A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61K 9/00 (2006.01); A61K 31/145 (2006.01); A61K 31/18 (2006.01); A61K 31/192 (2006.01); A61K 31/197 (2006.01); A61K 31/203 (2006.01); A61K 31/40 (2006.01); A61K 31/401 (2006.01); A61K 31/4164 (2006.01); A61K 31/438 (2006.01); A61K 31/444 (2006.01); A61K 31/575 (2006.01); A61K 31/616 (2006.01); A61K 31/65 (2006.01); A61K 31/7048 (2006.01); A61K 31/7056 (2006.01); A61K 38/26 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 48/00 (2006.01); C07D 491/107 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/0014 (2013.01); A61K 31/145 (2013.01); A61K 31/18 (2013.01); A61K 31/192 (2013.01); A61K 31/197 (2013.01); A61K 31/203 (2013.01); A61K 31/40 (2013.01); A61K 31/401 (2013.01); A61K 31/4164 (2013.01); A61K 31/438 (2013.01); A61K 31/444 (2013.01); A61K 31/575 (2013.01); A61K 31/616 (2013.01); A61K 31/65 (2013.01); A61K 31/7048 (2013.01); A61K 31/7056 (2013.01); A61K 38/26 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61K 48/005 (2013.01); A61P 1/16 (2018.01); A61P 3/04 (2018.01); A61P 17/10 (2018.01); C07D 491/107 (2013.01); C07D 519/00 (2013.01);
Abstract

Provided herein are spirolactone compounds of Formula I that are useful as inhibitors of ACC1 and/or ACC2. The spirolactone compounds described herein can be used for treating a disease or disorder associated with aberrant ACC1 and/or ACC2 activities, for example, non-alcoholic steatohepatitis (NASH), acne, obesity, diabetes, and cancer. Also provided herein are pharmaceutical compositions comprising the spirolactone compound of Formula I, or pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…